MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $48.19 Million Holdings in GE HealthCare Technologies Inc. $GEHC

Key Points

• MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in GE HealthCare Technologies Inc. by 16.4% during the first quarter, acquiring an additional 84,107 shares to reach a total of 597,092 shares valued at $48.19 million.
• GE HealthCare Technologies reported an earnings per share (EPS) of $1.06 for the last quarter, exceeding analysts' expectations of $0.91, with revenue of $5 billion compared to an expectation of $4.96 billion.
• The company has a quarterly dividend of $0.035 per share, which represents a 0.2% yield, and has a payout ratio of 2.87%.

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 16.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 597,092 shares of the company's stock after buying an additional 84,107 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned approximately 0.13% of GE HealthCare Technologies worth $48,190,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in GEHC. JPMorgan Chase & Co. lifted its position in shares of GE HealthCare Technologies by 49.9% in the first quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company's stock worth $414,894,000 after buying an additional 1,711,963 shares during the last quarter. Nuveen LLC acquired a new position in shares of GE HealthCare Technologies during the 1st quarter worth about $77,058,000. GAMMA Investing LLC lifted its position in shares of GE HealthCare Technologies by 9,524.6% during the 1st quarter. GAMMA Investing LLC now owns 771,507 shares of the company's stock worth $62,268,000 after purchasing an additional 763,491 shares during the last quarter. Jacobs Levy Equity Management Inc. lifted its position in shares of GE HealthCare Technologies by 41.6% during the 4th quarter. Jacobs Levy Equity Management Inc. now owns 2,451,179 shares of the company's stock worth $191,633,000 after purchasing an additional 719,866 shares during the last quarter. Finally, Deutsche Bank AG lifted its position in shares of GE HealthCare Technologies by 47.0% during the 4th quarter. Deutsche Bank AG now owns 1,754,468 shares of the company's stock worth $137,164,000 after purchasing an additional 561,008 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company's stock.

Analyst Ratings Changes

GEHC has been the subject of several research analyst reports. Morgan Stanley cut their price objective on GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating for the company in a research report on Thursday, July 31st. BTIG Research reissued a "buy" rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th. Citigroup boosted their price objective on GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a "buy" rating in a research report on Thursday, July 31st. Zacks Research raised GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a research report on Thursday, August 28th. Finally, Wall Street Zen raised GE HealthCare Technologies from a "hold" rating to a "buy" rating in a research report on Saturday, May 31st. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $88.40.

GE HealthCare Technologies Price Performance

Shares of GEHC stock traded down $2.72 during trading hours on Wednesday, hitting $75.99. The company had a trading volume of 4,101,699 shares, compared to its average volume of 3,968,745. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The firm has a market capitalization of $34.69 billion, a price-to-earnings ratio of 15.57, a PEG ratio of 2.99 and a beta of 1.13. The firm's fifty day moving average is $74.42 and its 200 day moving average is $73.83. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.93 and a current ratio of 1.16.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The company had revenue of $5 billion for the quarter, compared to analyst estimates of $4.96 billion. During the same period in the prior year, the company posted $1.00 EPS. The company's revenue was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 25th were paid a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date was Friday, July 25th. GE HealthCare Technologies's dividend payout ratio is currently 2.87%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.